Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jihan Youssef

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Thescientificworldjournal|June 14, 2003
Enhanced hepatocarcinogenicity due to agonists of peroxisome proliferator-activated receptors in senescent rats: role of peroxisome proliferation, cell proliferation, and apoptosisJihan Youssef, Mostafa Badr
Journal of Biomedicine & Biotechnology|August 5, 2004
Role of Peroxisome Proliferator-Activated Receptors in Inflammation ControlJihan Youssef, Mostafa Badr
British Journal of Pharmacology|April 1, 2011
Peroxisome proliferator-activated receptors and cancer: challenges and opportunitiesJihan Youssef, Mostafa Badr
Methods in Molecular Biology (Clifton, N.J.)|October 27, 2012
PPARs: history and advancesJihan Youssef, Mostafa Z Badr
Mechanisms of Ageing and Development|November 12, 2002
Senescence-associated decline in hepatic peroxisomal enzyme activities corresponds with diminished levels of retinoid X receptor alpha, but not peroxisome proliferator-activated receptor alphaChristine Chao, Jihan Youssef, Mohammad Rezaiekhaleigh, et al.
Journal of Carcinogenesis|March 12, 2003
Glucocorticoid-like effects of antihepatocarcinogen Rotenone are mediated via enhanced serum corticosterone levels: Molecular Fitting and Receptor Activation StudiesJihan Youssef, Cem Elbi, Barbour Warren, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Thescientificworldjournal|June 14, 2003
Enhanced hepatocarcinogenicity due to agonists of peroxisome proliferator-activated receptors in senescent rats: role of peroxisome proliferation, cell proliferation, and apoptosisJihan Youssef, Mostafa Badr
Journal of Biomedicine & Biotechnology|August 5, 2004
Role of Peroxisome Proliferator-Activated Receptors in Inflammation ControlJihan Youssef, Mostafa Badr
British Journal of Pharmacology|April 1, 2011
Peroxisome proliferator-activated receptors and cancer: challenges and opportunitiesJihan Youssef, Mostafa Badr
Methods in Molecular Biology (Clifton, N.J.)|October 27, 2012
PPARs: history and advancesJihan Youssef, Mostafa Z Badr
Mechanisms of Ageing and Development|November 12, 2002
Senescence-associated decline in hepatic peroxisomal enzyme activities corresponds with diminished levels of retinoid X receptor alpha, but not peroxisome proliferator-activated receptor alphaChristine Chao, Jihan Youssef, Mohammad Rezaiekhaleigh, et al.
Journal of Carcinogenesis|March 12, 2003
Glucocorticoid-like effects of antihepatocarcinogen Rotenone are mediated via enhanced serum corticosterone levels: Molecular Fitting and Receptor Activation StudiesJihan Youssef, Cem Elbi, Barbour Warren, et al.
Pageof 1